Fact checked by Jennifer Klump Adults aged 50 and older who have certain medical conditions are now eligible to get vaccinated against respiratory syncytial virus (RSV). Since the RSV vaccine was ...

Laboratorios Rovi (ROVI) will publish its Q2 2025 results on Thursday 24 July at 10 a.m. We expect some improvement on the ...

Sanofi is buying U.K. biotechnology company Vicebio for up to $1.6 billion in a deal that seeks to strengthen the French drugmaker's portfolio of respiratory vaccines and leave pipeline setbacks ...

Lebanese-born Armenian-American entrepreneur and philanthropist Noubar Afeyan has joined the likes of the world’s richest man ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

There’s still plenty of room for growth as the AI race continues to unfold. Still, some growth investors are already moving ...

Vladimir Sorokin. Photograph by Maria Sorokina. My problems started much earlier than the night before deadline—they started ...

The CDC declared the end of its emergency response to H5N1 avian flu as a health threat to humans, David Murray writes.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

When ticks bite us, they release thousands of proteins through their saliva. Could a vaccine for the right ones stop ticks ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...